Management of Palm Thorn Puncture Infections

Introduction to Treatment

The Infectious Diseases Society of America recommends amoxicillin-clavulanate as the first-line antibiotic for palm thorn puncture wound infections in the arm due to its broad coverage of both aerobic and anaerobic bacteria commonly found in these injuries 1, 2

Palm thorn puncture wounds present unique infection risks due to deep inoculation of plant material containing multiple bacterial species 3
The presence of both aerobic and anaerobic organisms in palm thorn puncture wounds necessitates broad-spectrum antibiotic coverage 2
The risk of foreign body retention, such as thorn fragments, contributes to the complexity of treating these infections 2

Common pathogens in plant thorn injuries include Staphylococcus aureus, Streptococcus species, Gram-negative organisms, anaerobic bacteria from soil/plant material, and Pasteurella multocida 1, 3, 4

The recommended first-line therapy is amoxicillin-clavulanate 875/125 mg twice daily, which provides excellent coverage against both aerobic and anaerobic organisms 1, 2, 3
For penicillin-allergic patients, doxycycline 100 mg twice daily is an alternative option, offering good activity against staphylococci and some anaerobes 3, 4
Moxifloxacin 400 mg daily is another alternative, providing good anaerobic coverage, although it is not first-line due to fluoroquinolone stewardship concerns 1, 3, 5

For severe infections requiring IV therapy, ampicillin-sulbactam 1.5-3.0 g every 6-8 hours or piperacillin-tazobactam 3.37 g every 6-8 hours are recommended 3

The duration of therapy for uncomplicated infections is 5-7 days, with extension of treatment if the infection has not improved within this period 6

Thorough irrigation and debridement to remove foreign material, along with consideration of imaging for retained foreign bodies and tetanus prophylaxis, are essential components of wound care 1, 7
MRSA coverage should be considered in patients with a prior history of MRSA, initial treatment failure, severe immunocompromise, or presence of systemic inflammatory response syndrome (SIRS) 5

Immunocompromised patients require more aggressive therapy, including broader spectrum coverage and a lower threshold for IV therapy and hospitalization 2
In pediatric patients, amoxicillin-clavulanate remains the first-line therapy, with dosing based on the amoxicillin component 5